Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» psoriasis
psoriasis
Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany
CP Wire
Wed, 06/13/18 - 10:19 pm
JNJ
NICE
Tremfya
psoriasis
Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany
Wed, 06/13/18 - 10:19 pm
JNJ
Tremfya
psoriasis
Two drugs in the pipeline representing unique marketing challenges
Medical Marketing and Media
Tue, 06/5/18 - 10:37 pm
valrox
Biomarin
hepatitis A
risankizumab
AbbVie
Boehringer Ingelheim
psoriasis
US approves UCB’s Cimzia for psoriasis
Pharma Times
Tue, 05/29/18 - 09:16 pm
FDA
UCB Pharma
Cimzia
psoriasis
AbbVie Submits Marketing Application to the European Medicines Agency for Risankizumab in Plaque Psoriasis
CP Wire
Tue, 05/1/18 - 09:25 pm
AbbVie
EMA
Europe
risankizumab
psoriasis
AbbVie Submits Marketing Application to the European Medicines Agency for Risankizumab in Plaque Psoriasis
Tue, 05/1/18 - 10:08 am
AbbVie
psoriasis
risankizumab
UCB Receives Positive CHMP Opinion for Cimzia in Moderate-to-Severe Plaque Psoriasis
CP Wire
Sat, 04/28/18 - 11:56 am
UCB Pharma
CHMP
Cimzia
psoriasis
UCB Receives Positive CHMP Opinion for Cimzia in Moderate-to-Severe Plaque Psoriasis
Sat, 04/28/18 - 11:55 am
UCB Pharmaceuticals
Cimzia
psoriasis
Will Ilumya Kill Valeant's Psoriasis Dreams?
Seeking Alpha
Wed, 04/18/18 - 07:27 pm
Sun Pharma
Ilumya
FDA
psoriasis
Siliq
Valeant Pharmaceuticals
Sun Pharma Receives Approval for New Plaque Psoriasis Drug
CP Wire
Wed, 03/21/18 - 10:25 am
Sun Pharma
psoriasis
Ilumya
FDA
An immunotherapy pill for psoriasis? Escalier gets $19M Series B to tackle R&D
Endpoints
Tue, 03/13/18 - 09:31 pm
immunotherapy
psoriasis
Escalier
R&D
Novartis beefs up its data bank on Cosentyx’s durable effect on quality of life as well as scalp psoriasis
Endpoints
Fri, 02/16/18 - 09:32 pm
Novartis
Cosentyx
psoriasis
Novartis goes 2-0 against J&J in psoriasis
Biopharma Dive
Wed, 01/17/18 - 11:36 am
Novartis
JNJ
psoriasis
Cosentyx
Stelara
Novartis Starts Trial on Psoriasis Drug Cosentyx Biosoimilar
Yahoo/Zacks.com
Wed, 01/10/18 - 10:18 am
Novartis
psoriasis
Cosentyx
biosimilars
ankylosing spondylitis
In a crowded market, AbbVie may still have a best-in-class psoriasis prospect up its sleeve: analyst
Fierce Pharma
Wed, 12/6/17 - 09:53 am
AbbVie
psoriasis
risankizumab
JNJ
Tremfya
AbbVie's stock climbs after positive late-stage trial results of psoriasis treatment
Marketwatch
Mon, 12/4/17 - 09:48 am
AbbVie
psoriasis
risankizumab
clinical trials
A Me-Too Push By Biopharma Is Crowding the Psoriasis Market
Motley Fool
Sun, 10/29/17 - 09:59 am
psoriasis
me-too drugs
Otezla
Celgene
AbbVie boasts a PhIII sweep for top psoriasis contender risankizumab, but it has lots of competition
Endpoints
Thu, 10/26/17 - 09:28 am
AbbVie
psoriasis
risankizumab
Humira
Stelara
clinical trials
J&J psoriasis drug gets expanded U.S. approval for teens
Yahoo/Reuters
Sat, 10/14/17 - 10:58 am
JNJ
Stelara
psoriasis
FDA
Thync’s bioelectronics wearable shows promise in psoriasis pilot
Fierce Biotech
Thu, 10/5/17 - 12:48 pm
Thync
wearables
psoriasis
bioelectronics
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »